Skip to main content
. 2022 Sep 20;14(9):e29354. doi: 10.7759/cureus.29354

Figure 11. Cancer stemness is required to maintain the myCAF phenotype.

Figure 11

MDA-MB-231 cells were treated with cancer stemness inhibitor BBI608 at different concentrations for 48 hours. Cancer stemness markers Sox2/Oct4/Nanog mRNA expression were quantified by real time PCR.